curcumin major constituent turmeric corrects cystic fibrosis defects 
cystic fibrosis caused mutations gene encoding cystic fibrosis transmembrane conductance regulator cftr common mutation deltaf508 results production misfolded cftr protein retained endoplasmic reticulum targeted degradation curcumin nontoxic ca-adenosine triphosphatase pump inhibitor can administered humans safely oral administration curcumin homozygous deltaf508 cftr mice doses comparable weight-per-weight basis well tolerated humans corrected animals characteristic nasal potential difference defect effects observed mice homozygous complete knockout cftr gene curcumin also induced functional appearance deltaf508 cftr protein plasma membranes transfected baby hamster kidney cells thus curcumin treatment may able correct defects associated homozygous expression deltaf508 cftr 
